SEATTLE (AP) — In 2016, hospitals in New York state identified a rare and dangerous fungal infection never before found in the United States. Research laboratories quickly mobilized to review historical specimens and found the fungus had been present in the country since at least 2013.
In the years since, New York City has emerged as ground zero for Candida auris infections. And until 2021, the state recorded the most confirmed cases in the country year after year, even as the illness has spread to other places, according to Centers for Disease Control and Prevention (CDC) data analyzed by The Associated Press.
Candida auris is a globally emerging public health threat that can cause severe illness, including bloodstream, wound and respiratory infections. Its mortality rate has been estimated at 30% to 60%, and it’s a particular risk in healthcare settings for people already with serious medical problems.
Last year, the most cases were found in Nevada and California, but the fungus was identified clinically in patients in 29 states. New York state remains a major hotspot.
A prominent theory for the sudden explosion of Candida auris, which was not found in humans anywhere until 2009, is climate change.
Comments